350 related articles for article (PubMed ID: 23323988)
1. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review.
Davies MJ; Gagliardino JJ; Gray LJ; Khunti K; Mohan V; Hughes R
Diabet Med; 2013 May; 30(5):512-24. PubMed ID: 23323988
[TBL] [Abstract][Full Text] [Related]
2. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
3. Insulin adherence in patients with diabetes: risk factors for injection omission.
Farsaei S; Radfar M; Heydari Z; Abbasi F; Qorbani M
Prim Care Diabetes; 2014 Dec; 8(4):338-45. PubMed ID: 24721139
[TBL] [Abstract][Full Text] [Related]
4. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.
Peyrot M; Barnett AH; Meneghini LF; Schumm-Draeger PM
Diabet Med; 2012 May; 29(5):682-9. PubMed ID: 22313123
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study.
Peyrot M; Barnett AH; Meneghini LF; Schumm-Draeger PM
Diabetes Obes Metab; 2012 Dec; 14(12):1081-7. PubMed ID: 22726104
[TBL] [Abstract][Full Text] [Related]
6. FlexPen: addressing issues of confidence and convenience in insulin delivery.
Korytkowski M; Niskanen L; Asakura T
Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040
[TBL] [Abstract][Full Text] [Related]
7. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
8. Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project.
Ratanawongsa N; Crosson JC; Schillinger D; Karter AJ; Saha CK; Marrero DG
Diabetes Educ; 2012; 38(1):94-100. PubMed ID: 22222513
[TBL] [Abstract][Full Text] [Related]
9. Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment.
Ayyagari R; Wei W; Cheng D; Pan C; Signorovitch J; Wu EQ
Value Health; 2015 Mar; 18(2):198-205. PubMed ID: 25773555
[TBL] [Abstract][Full Text] [Related]
10. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic.
Huang YM; Shiyanbola OO; Chan HY; Smith PD
Postgrad Med; 2020 May; 132(4):328-336. PubMed ID: 32233892
[TBL] [Abstract][Full Text] [Related]
11. The association between health beliefs and medication adherence among patients with type 2 diabetes.
Alatawi YM; Kavookjian J; Ekong G; Alrayees MM
Res Social Adm Pharm; 2016; 12(6):914-925. PubMed ID: 26706405
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for improving adherence to type 2 diabetes mellitus therapy--focus on optimizing insulin-based therapy.
Campbell RK
Am J Manag Care; 2012 Apr; 18(3 Suppl):S55-61. PubMed ID: 22558943
[TBL] [Abstract][Full Text] [Related]
13. Considerations for diabetes: treatment with insulin pen devices.
Cuddihy RM; Borgman SK
Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
[TBL] [Abstract][Full Text] [Related]
14. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes.
Clifford S; Perez-Nieves M; Skalicky AM; Reaney M; Coyne KS
Curr Med Res Opin; 2014 Jun; 30(6):1071-85. PubMed ID: 24432796
[TBL] [Abstract][Full Text] [Related]
15. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
[TBL] [Abstract][Full Text] [Related]
16. An analysis of patient acceptance and safety of a prefilled insulin injection device.
Kroon L
J Diabetes Sci Technol; 2009 Nov; 3(6):1439-41. PubMed ID: 20144399
[TBL] [Abstract][Full Text] [Related]
17. Patients' characteristics and their adherence to insulin therapy.
Fitriani Y; Pristianty L; Hermansyah A
J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31940288
[TBL] [Abstract][Full Text] [Related]
18. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
19. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
Asche CV; Shane-McWhorter L; Raparla S
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
[TBL] [Abstract][Full Text] [Related]
20. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
